BCM
TDOC icon

Blume Capital Management’s Teladoc Health TDOC Stock Holding History

Blume Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-56
Closed -$4K – 340
2022
Q1 		$4K Buy
+56
New +$4.03K ﹤0.01% 294

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Blume Capital Management's TDOC Position: Q2 2022 in Review

Blume Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 56 shares — an estimated $4K sold.

Blume Capital Management first reported a position in TDOC in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Blume Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Blume Capital Management sold 56 Teladoc Health shares in Q2 2022, an estimated $4K.
  • Blume Capital Management first reported a position in Teladoc Health in Q1 2022 and held it in 1 quarter.
  • Blume Capital Management's Teladoc Health position peaked at $4K in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Blume Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.